{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T19:27:42Z","timestamp":1754162862252,"version":"3.41.2"},"reference-count":53,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Providers caring for children with end-stage kidney disease from rheumatologic conditions face questions such as when to proceed with kidney transplantation, how common is disease recurrence posttransplant, how does recurrent disease impact patient and allograft outcomes, and what approaches are available to prevent and treat recurrent disease. We discuss recent developments and relevant literature that address these questions for the most common rheumatologic disorders that lead to end-stage kidney disease in childhood namely, systemic lupus erythematosus, IgA nephropathy, IgA Vasculitis\/Henoch Schoenlein Purpura, and Anti-Neutrophil Cytoplasmic Antibody (ANCA)-associated vasculitis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Recent data suggest that children with IgA nephropathy, IgA vasculitis, and ANCA-associated vasculitis have similar patient and allograft survival to other conditions despite the risk of recurrent disease, yet those with lupus have worse posttransplant patient and allograft outcomes. A period of disease quiescence may be prudent prior to transplantation to decrease the risk of recurrence, which is associated with decreased allograft survival. Data on preventive strategies and treatment options are limited.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>It is recommended that patients with systemic rheumatologic conditions not be excluded from kidney transplantation but that patients be counseled on the risk of potential recurrent disease with its impact on transplant outcomes.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mop.0000000000001100","type":"journal-article","created":{"date-parts":[[2021,12,26]],"date-time":"2021-12-26T18:00:19Z","timestamp":1640541619000},"page":"234-240","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Kidney transplantation in pediatric patients with rheumatologic disorders"],"prefix":"10.1097","volume":"34","author":[{"given":"Ellen","family":"Cody","sequence":"first","affiliation":[{"name":"Division of Nephrology and Hypertension, Cincinnati Children's Hospital Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David K.","family":"Hooper","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Pediatrics, Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,12,24]]},"reference":[{"key":"R2-20250730","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1093\/ndt\/gfx372","article-title":"Impact of graft loss among kidney diseases with a high risk of posttransplant recurrence in the paediatric population","volume":"33","author":"Van Stralen","year":"2018","journal-title":"Nephrol Dialysis Transplant"},{"key":"R3-20250730","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1056\/NEJMoa013036","article-title":"Risk of renal allograft loss from recurrent glomerulonephritis","volume":"347","author":"Briganti","year":"2002","journal-title":"N Engl J Med"},{"key":"R4-20250730","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/1756-185X.12419","article-title":"Childhood onset systemic lupus erythematosus: how is it different from adult SLE?","volume":"18","author":"Aggarwal","year":"2015","journal-title":"Int J Rheum Dis"},{"key":"R5-20250730","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.kint.2021.05.015","article-title":"Executive summary of the KDIGO 2021 guideline for the management of glomerular diseases","volume":"100","author":"Rovin","year":"2021","journal-title":"Kidney Int"},{"key":"R6-20250730","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1016\/S0140-6736(21)00578-X","article-title":"Efficacy and safety of voclosporin versus placebo for lupus nephritis [AURORA 1]: a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial","volume":"397","author":"Rovin","year":"2021","journal-title":"Lancet"},{"key":"R7-20250730","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1056\/NEJMoa2001180","article-title":"Two-year, randomized, controlled trial of belimumab in lupus nephritis","volume":"383","author":"Furie","year":"2020","journal-title":"New Engl J Med"},{"key":"R8-20250730","doi-asserted-by":"crossref","first-page":"e000355","DOI":"10.1136\/lupus-2019-000355","article-title":"Belatacept in kidney transplant patients with systemic lupus erythematosus","volume":"6","author":"Carrion-Barbera","year":"2019","journal-title":"Lupus Sci Med"},{"key":"R9-20250730","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1053\/j.ackd.2019.08.007","article-title":"Lupus nephritis and kidney transplantation: where are we today?","volume":"26","author":"Wong","year":"2019","journal-title":"Adv Chronic Kidney Dis"},{"key":"R10-20250730","doi-asserted-by":"crossref","first-page":"11611","DOI":"10.1038\/s41598-019-48070-y","article-title":"Outcome and prognosis of patients with lupus nephritis submitted to renal transplantation","volume":"9","author":"Albuquerque","year":"2019","journal-title":"Sci Rep"},{"key":"R11-20250730","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1177\/09612033211028663","article-title":"Kidney transplantation outcomes in lupus nephritis: a 37-year single-center experience from Latin America","volume":"30","author":"Rodelo","year":"2021","journal-title":"Lupus"},{"issue":"(4S1 Suppl 1)","key":"R12-20250730","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1097\/TP.0000000000003136","article-title":"KDIGO Clinical Practice Guideline on the evaluation and management of candidates for kidney transplantation","volume":"104","author":"Chadban","year":"2020","journal-title":"Transplantation"},{"key":"R13-20250730","article-title":"Dialysis outcomes for children with lupus nephritis compared to children with other forms of nephritis: a retrospective cohort study","author":"Wasik","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"R14-20250730","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1007\/s00467-009-1137-6","article-title":"Disease recurrence in paediatric renal transplantation","volume":"24","author":"Cochat","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"R15-20250730","doi-asserted-by":"crossref","first-page":"104021","DOI":"10.1016\/j.cellimm.2019.104021","article-title":"Recurrence of disease following organ transplantation in autoimmune liver disease and systemic lupus erythematosus","volume":"347","author":"Tanaka","year":"2020","journal-title":"Cell Immunol"},{"key":"R16-20250730","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.semarthrit.2016.09.008","article-title":"The utility of lupus serology in predicting outcomes of renal transplantation in lupus patients: systematic literature review and analysis of the Toronto lupus cohort","volume":"46","author":"Yap","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"R17-20250730","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1177\/0961203320902524","article-title":"Transplant outcomes in kidney recipients with lupus nephritis, and systematic review","volume":"29","author":"Kim","year":"2020","journal-title":"Lupus"},{"key":"R18-20250730","doi-asserted-by":"crossref","first-page":"720","DOI":"10.6002\/ect.2019.0138","article-title":"Long-term outcomes of renal transplant in patients with end-stage renal failure due to systemic lupus erythematosus and granulomatosis with polyangiitis","volume":"17","author":"Considine","year":"2019","journal-title":"Exp Clin Transplant"},{"key":"R19-20250730","first-page":"e14178","article-title":"Kidney transplant outcomes in children and adolescents with systemic lupus erythematosus","author":"Mai","year":"2021","journal-title":"Pediatr Transplant"},{"key":"R20-20250730","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1002\/art.30350","article-title":"End-stage renal disease due to lupus nephritis among children in the US","volume":"63","author":"Hiraki","year":"2011","journal-title":"Arthritis Rheum"},{"key":"R21-20250730","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1093\/ndt\/gfr731","article-title":"The impact of mycophenolate mofetil versus azathioprine as adjunctive therapy to cyclosporine on the rates of renal allograft loss due to glomerular disease recurrence","volume":"27","author":"Pham","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"R22-20250730","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.2215\/CJN.01410211","article-title":"Long-term outcome of renal transplantation patients with Henoch-Schonlein purpura","volume":"6","author":"Samuel","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"R23-20250730","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.2215\/CJN.00910121","article-title":"Recurrence of IgA nephropathy after kidney transplantation in adults","volume":"16","author":"Uffing","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"key":"R24-20250730","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1097\/TP.0b013e31822e0bcf","article-title":"Histologic recurrence of Henoch-Schonlein Purpura nephropathy after renal transplantation on routine allograft biopsy","volume":"92","author":"Thervet","year":"2011","journal-title":"Transplantation"},{"key":"R25-20250730","first-page":"227","article-title":"Different recurrence rates between pediatric and adult renal transplant for immunoglobulin A nephropathy: predictors of posttransplant recurrence","volume":"13","author":"Ahn","year":"2015","journal-title":"Exp Clin Transplant"},{"key":"R26-20250730","doi-asserted-by":"crossref","first-page":"726215","DOI":"10.3389\/fimmu.2021.726215","article-title":"Outcome of 313 Czech patients with IgA nephropathy after renal transplantation","volume":"12","author":"Maixnerova","year":"2021","journal-title":"Front Immunol"},{"key":"R27-20250730","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/ckj\/sfaa060","article-title":"Recurrence of immunoglobulin A nephropathy after kidney transplantation: a narrative review of the incidence, risk factors, pathophysiology and management of immunosuppressive therapy","volume":"13","author":"Infante","year":"2020","journal-title":"Clin Kidney J"},{"key":"R28-20250730","doi-asserted-by":"crossref","first-page":"5954","DOI":"10.3390\/ijms21175954","article-title":"Recurrent glomerulonephritis after renal transplantation: the clinical problem","volume":"21","author":"Infante","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R29-20250730","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/j.1432-2277.2012.01483.x","article-title":"Recurrence from primary and secondary glomerulopathy after renal transplant","volume":"25","author":"Canaud","year":"2012","journal-title":"Transpl Int"},{"key":"R30-20250730","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.kint.2017.03.015","article-title":"Recurrent glomerulonephritis after kidney transplantation: risk factors and allograft outcomes","volume":"92","author":"Allen","year":"2017","journal-title":"Kidney Int"},{"key":"R31-20250730","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12882-016-0435-z","article-title":"Increased glomerulonephritis recurrence after living related donation","volume":"18","author":"Kennard","year":"2017","journal-title":"BMC Nephrol"},{"key":"R32-20250730","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/nep.12629","article-title":"Long-term outcomes of end-stage kidney disease for patients with IgA nephropathy: a multicentre registry study","volume":"21","author":"Zhang","year":"2016","journal-title":"Nephrology (Carlton)"},{"key":"R33-20250730","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1186\/s12882-018-1135-7","article-title":"Recurrent glomerulonephritis following renal transplantation and impact on graft survival","volume":"19","author":"Jiang","year":"2018","journal-title":"BMC Nephrol"},{"key":"R34-20250730","doi-asserted-by":"crossref","first-page":"e0253337","DOI":"10.1371\/journal.pone.0253337","article-title":"Kidney transplantation outcomes in patients with IgA nephropathy and other glomerular and nonglomerular primary diseases in the new era of immunosuppression","volume":"16","author":"Lionaki","year":"2021","journal-title":"PloS One"},{"key":"R35-20250730","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/j.transproceed.2019.01.115","article-title":"Impact of induction immunosuppression on the recurrence of primary IgA nephropathy","volume":"51","author":"Lee","year":"2019","journal-title":"Transplant Proc"},{"key":"R36-20250730","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1016\/j.transproceed.2020.05.022","article-title":"Reduced recurrence of primary IgA nephropathy in kidney transplant recipients receiving everolimus with corticosteroid: a retrospective, single-center study of 135 transplant patients","volume":"52","author":"Noguchi","year":"2020","journal-title":"Transplant Proc"},{"key":"R37-20250730","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.3390\/jcm10173939","article-title":"Comparative long-term renal allograft outcomes of recurrent immunoglobulin A with severe activity in kidney transplant recipients with and without rituximab: an observational cohort study","volume":"10","author":"Chancharoenthana","year":"2021","journal-title":"J Clin Med"},{"key":"R38-20250730","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/tri.13075","article-title":"Recurrence of IgA nephropathy after kidney transplantation in steroid continuation versus early steroid-withdrawal regimens: a retrospective analysis of the UNOS\/OPTN database","volume":"31","author":"Leeaphorn","year":"2018","journal-title":"Transpl Int"},{"key":"R39-20250730","doi-asserted-by":"crossref","first-page":"e13207","DOI":"10.1111\/ctr.13207","article-title":"Recurrent IgA nephropathy after renal transplantation and steroid withdrawal","volume":"32","author":"Di Vico","year":"2018","journal-title":"Clin Transplant"},{"key":"R40-20250730","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.2215\/CJN.00280121","article-title":"Recurrent glomerular disease after kidney transplantation: diagnostic and management dilemmas","volume":"16","author":"Uffing","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"key":"R41-20250730","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1007\/s00467-017-3749-6","article-title":"Outcome of kidney transplantation in pediatric patients with ANCA-associated glomerulonephritis: a single-center experience","volume":"32","author":"Noone","year":"2017","journal-title":"Pediatr Nephrol"},{"key":"R42-20250730","doi-asserted-by":"crossref","first-page":"e13656","DOI":"10.1111\/petr.13656","article-title":"Long-term outcome of renal transplantation in childhood-onset antineutrophil cytoplasmic antibody-associated vasculitis","volume":"24","author":"Nagasawa","year":"2020","journal-title":"Pediatr Transplant"},{"key":"R43-20250730","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.2215\/CJN.19181220","article-title":"Prognostic factors and long-term outcome with ANCA-associated kidney vasculitis in childhood","volume":"16","author":"Calatroni","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"key":"R44-20250730","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s40620-015-0253-6","article-title":"Relevance of ANCA positivity at the time of renal transplantation in ANCA associated vasculitis","volume":"30","author":"Geetha","year":"2017","journal-title":"J Nephrol"},{"key":"R45-20250730","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1097\/TP.0b013e31821ab9aa","article-title":"Renal transplantation in antineutrophil cytoplasmic antibody-associated vasculitis: a multicenter experience","volume":"91","author":"Geetha","year":"2011","journal-title":"Transplantation"},{"key":"R46-20250730","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1399-0012.2010.01248.x","article-title":"Outcomes of renal transplantation in recipients with Wegener's granulomatosis","volume":"25","author":"Shen","year":"2011","journal-title":"Clin Transplant"},{"key":"R47-20250730","article-title":"Practice patterns and outcomes for pediatric ANCA vasculitis transplant recipients in a national cohort","author":"Kilduff","year":"2021","journal-title":"Pediatr Nephrol"},{"key":"R48-20250730","doi-asserted-by":"crossref","first-page":"e14235","DOI":"10.1111\/ctr.14235","article-title":"Allograft failure in kidney transplant recipients who developed kidney failure secondary to ANCA-associated vasculitis","volume":"35","author":"Kuhnel","year":"2021","journal-title":"Clin Transplant"},{"key":"R49-20250730","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000505660","article-title":"Renal transplantation in antineutrophil cytoplasmic antibody-associated vasculitis: current perspectives","volume":"45","author":"Hruskova","year":"2020","journal-title":"Kidney Blood Press Res"},{"key":"R50-20250730","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1097\/TP.0000000000000910","article-title":"The Dutch Transplantation in Vasculitis [DUTRAVAS] Study: outcome of renal transplantation in antineutrophil cytoplasmic antibody-associated glomerulonephritis","volume":"100","author":"Goceroglu","year":"2016","journal-title":"Transplantation"},{"key":"R51-20250730","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1038\/sj.ki.5002244","article-title":"Recurrence of ANCA-associated vasculitis following renal transplantation in the modern era of immunosupression","volume":"71","author":"Gera","year":"2007","journal-title":"Kidney Int"},{"key":"R52-20250730","doi-asserted-by":"crossref","first-page":"194","DOI":"10.55563\/clinexprheumatol\/7jue09","article-title":"Belatacept as maintenance therapy in kidney transplant recipients with ANCA-associated vasculitis","volume":"39 Suppl 129","author":"Martins","year":"2021","journal-title":"Clin Exp Rheumatol"},{"key":"R53-20250730","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s40620-019-00642-x","article-title":"Kidney transplantation in ANCA-associated vasculitis","volume":"32","author":"Sagmeister","year":"2019","journal-title":"J Nephrol"},{"key":"R54-20250730","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1053\/j.ajkd.2015.03.025","article-title":"Characteristics and outcomes of granulomatosis with polyangiitis [Wegener] and microscopic polyangiitis requiring renal replacement therapy: results from the European Renal Association-European Dialysis and Transplant Association Registry","volume":"66","author":"Hruskova","year":"2015","journal-title":"Am J Kidney Dis"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000001100","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T18:10:38Z","timestamp":1753899038000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000001100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,24]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0000000000001100","relation":{},"ISSN":["1040-8703","1531-698X"],"issn-type":[{"type":"print","value":"1040-8703"},{"type":"electronic","value":"1531-698X"}],"subject":[],"published":{"date-parts":[[2021,12,24]]}}}